DOT1L and breast carcinoma: In addition, fluorescence staining of double-stranded DNA (dsDNA) revealed cytoplasmic DNA foci in breast cancer cells treated with a DOT1L inhibitor, indicating increased levels of cytosolic DNA upon DOT1L inhibition (Supplementary Fig. S11).